AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 284: R28-R30, 2003; doi:10.1152/ajpregu.00531.2002
0363-6119/03 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehmke, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehmke, H.
Vol. 284, Issue 1, R28-R30, January 2003

IN FOCUS
Mouse gene targeting in cardiovascular physiology

Heimo Ehmke

Institut für Vegetative Physiologie und Pathophysiologie, Universität Hamburg, D-20246 Hamburg, Germany


    ARTICLE
TOP
ARTICLE
REFERENCES

IN THE 1980S A REVOLUTION took place in cardiovascular physiology unnoticed by many researchers working in the field. At that time, the rat and the dog were the prime animal models to study integrative mechanisms involved in cardiovascular regulation. The notorious but true saying that cells do not have a blood pressure implies that in vivo experiments will always be critical in the process of discovering new principles of circulatory control. Studies in rats and dogs have helped to unravel many basic principles of cardiovascular physiology, such as autoregulation of blood flow (11, 28), reflex control of blood pressure (3), or blood volume regulation through signals originating from the heart (2), to name just a few. Nevertheless, the lack of techniques to directly link the activity of specific genes to physiological functions---which was then possible already in cellular systems---remained a major drawback. Thus the development of experimental procedures to induce mutations in single genes and the eventual successful generation of mice carrying a targeted mutation in 1989 (7, 19) marked the beginning of a new era area also in cardiovascular physiology.

Today, more than 3,000 different knockout mice have been constructed. Many of these mutations affect cardiovascular function, and some of them have helped to solve long-standing open questions in cardiovascular regulation. For example, it has been known for long that the tubuloglomerular feedback (TGF) is a key mechanism of autoregulation of renal blood flow and glomerular filtration and is intimately involved in blood volume homeostasis. In the kidney, the proximal part of the distal tubule gets in close contact with the afferent arteriole to form the juxtaglomerular apparatus. Within this region, the TGF communicates changes in proximal tubular flow rate to afferent arteriolar smooth muscle and renin-secreting cells, causing a decrease in vascular tone and an increase in renin secretion rate if tubular flow rate falls and vice versa. Twenty years ago it was postulated that changes in local adenosine concentrations contribute to the signaling mechanism underlying the TGF response; however, participation of adenosine has remained controversial. Now two independent groups of investigators reported that mice carrying a targeted deletion of the A1-adenosine receptor, which is expressed at a high level in the juxtaglomerular apparatus, completely lack a TGF response (5, 34). These studies clearly demonstrate that adenosine, the major agonist of A1-adenosine receptors, plays an essential role in the signaling cascade mediating the TGF. Future studies will have to show whether this role is that of a mediator or a modulator (25, 29).

This example illustrates the major strength of the genetic approach compared with the more classical pharmacological and correlative approaches. Although the latter are inherently indirect, pharmacological studies often suffer from uncertain pharmacokinetics and a lack of specificity. Accordingly, the observation of a sevenfold higher salt intake after an overnight fluid restriction in mice carrying a targeted deletion of the oxytocin gene constitutes strong direct evidence for the concept derived from infusion studies of agonists and antagonists that sodium appetite is negatively regulated by central oxytocin (1). The finding that mice lacking tumor necrosis factor-alpha (TNF-alpha ) display threefold elevated renal renin mRNA levels under control conditions as well as after salt depletion provides the first in vivo evidence for a possible physiological function of TNF-alpha as a negative regulator of renin synthesis (35). Studies in TNF-alpha -/- mice also indicate that a strong increase in the local production of TNF-alpha initiates intimal hyperplasia after vascular injury (38). Further examples for important advances in our understanding of cardiovascular regulation obtained by the use of gene-targeted mice are the discovery of a major role of the K+ channel beta -subunit KCNE1 in K+ and renal fluid homeostasis (36), the unmasking of an enhanced central response to dehydration in angiotensin AT1A -/- mice (24), the identification of multiple physiological functions of alpha 2-adrenergic receptors (27),and the demonstration that the vagal effects on atrial rate are independent from M3-muscarinic receptor signaling (33).

In accordance with its increasing importance in cardiovascular research, the basic physiology of the murine circulatory system has been intensively studied recently. Most relevant techniques and experimental protocols to assess cardiovascular function have now been adapted to the small size of the mouse. These include chronic measurements of blood pressure (6, 14, 21, 23) and cardiac output (16), the analysis of the different components of the baroreceptor reflex (22), and renal function and balance studies (21). Many aspects of the murine cardiovascular system---anatomic and physiological---are identical to larger mammals. Nearly all values of cardiovascular parameters obtained in mice are well within the range predicted by allometric scaling equations from rats and humans (15). The baroreceptor reflex (22) and the regulation of fluid and electrolyte homeostasis by the renin-angiotensin system (8), two of the major blood pressure regulating systems (30, 32), seem to function in a very similar fashion as in larger mammals.

Nevertheless, there are also important peculiarities specific to the mouse. For example, studies using autonomic blocking agents indicate that mice generate a high resting cardiac sympathetic tone (14, 17). Mice have a relatively labile blood pressure and are extremely sensitive to stressful conditions such as anesthesia (21) and changes in ambient temperature (37). Sympathetic neurotransmitter release is also enhanced by stressful housing conditions, such as social deprivation and exposure to novel odors (9). A negative energy balance can cause severe hypotension and bradycardia in mice, possibly resulting in torporlike states (37). The development of hypotension is accelerated if mice are housed at an ambient temperature of 23°C, which is the normal room temperature in most laboratories. Dietary preferences (31) as well as metabolic responses to leptin (13) differ between strains and can confound cardiovascular measurements. The metabolism of melatonin is also strain dependent (18), which may impact on circadian cardiovascular rhythms. These factors need to be considered when designing experiments in mice.

It is very likely that targeted deletions will be introduced into most of the mouse's ~30,000 genes within the next few years. Keeping in mind the murine peculiarities listed above, the combination of mouse genetics and physiology seems to have a bright future. There are, however, several caveats. Most importantly, the vast majority of targeted deletions inactivate the target gene in each cell from conception onward. Such a lifelong deletion of gene function cannot only severely alter developmental processes, but might also disturb the normal homeostatic balance, causing secondary and/or compensatory up- and downregulation at the level of the genome as well as the level of the organism. Thus more subtle genetic constructs will be required, such as conditional targeted deletions and combinations of gene inactivations with the introduction of transgenes that restrict the expression of a specific gene to a limited area (e.g., in the central nervous system) or time (e.g., during development) (10, 20). Furthermore, although gene targeting is a very efficient way to investigate the function of a certain gene, it is considerably less powerful to uncover the genetic pathways underlying a given physiological process, particularly if the biology of this process is only poorly understood. In this latter situation, mutagenesis screens are much more likely to yield new insights. Such screens, however, require huge numbers of animals to be generated, housed, and phenotyped. Even though mutagenesis screens are already performed in mice, they can be realized much easier in the zebrafish (4, 26). And, finally, despite all the similarities between mice, rat, and humans, we will always need research that translates the results obtained in mice to the human physiology and pathophysiology (12).


    FOOTNOTES

Address for reprint requests and other correspondence: H. Ehmke, Institut für Vegetative Physiologie und Pathophysiologie, Universität Hamburg, Martinistrasse 52, D-20246 Hamburg, Germany (E-mail: ehmke{at}uke.uni-hamburg.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpregu.00531.2002


    REFERENCES
TOP
ARTICLE
REFERENCES

1.   Amico, JA, Morris M, and Vollmer RR. Mice deficient in oxytocin manifest increased saline consumption following overnight fluid deprivation. Am J Physiol Regul Integr Comp Physiol 281: R1368-R1373, 2001[Abstract/Free Full Text].

2.   Andersen, JL, Sandgaard NCF, and Bie P. Volume expansion during acute angiotensin II receptor (AT1) blockade and NOS inhibition in conscious dogs. Am J Physiol Regul Integr Comp Physiol 282: R1140-R1148, 2002[Abstract/Free Full Text].

3.   Baldridge, BR, Burgess DE, Zimmerman EE, Carroll JJ, Sprinkle AG, Speakman RO, Li SG, Brown DR, Taylor RF, Dworkin S, and Randall DC. Heart rate-arterial blood pressure relationship in conscious rat before vs. after spinal cord transection. Am J Physiol Regul Integr Comp Physiol 283: R748-R756, 2002[Abstract/Free Full Text].

4.   Briggs, JP. The zebrafish: a new model organism for integrative physiology. Am J Physiol Regul Integr Comp Physiol 282: R3-R9, 2002[Abstract/Free Full Text].

5.   Brown, R, Ollerstam A, Johansson B, Skøtt O, Gebre-Medhin S, Fredholm B, and Persson AEG Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362-R1367, 2001[Abstract/Free Full Text].

6.   Butz, GM, and Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5: 89-97, 2001[Abstract/Free Full Text].

7.   Capecchi, MR. Altering the genome by homologous recombination. Science 244: 1288-1292, 1989[Abstract/Free Full Text].

8.   Cholewa, BC, and Mattson DL. Role of the renin-angiotensin system during alterations of sodium intake in conscious mice. Am J Physiol Regul Integr Comp Physiol 281: R987-R993, 2001[Abstract/Free Full Text].

9.   D'Arbe, M, Einstein R, and Lavidis NA. Stressful animal housing conditions and their potential effect on sympathetic neurotransmission in mice. Am J Physiol Regul Integr Comp Physiol 282: R1422-R1428, 2002[Abstract/Free Full Text].

10.   Dono, R, Faulhaber J, Galli A, Zuniga A, Volk T, Texido G, Zeller R, and Ehmke H. FGF2 signaling is required for the development of neuronal circuits regulating blood pressure. Circ Res 90: E5-E10, 2002[Abstract/Free Full Text].

11.   Feng, MG, Dukacz SAW, and Kline RL. Selective effect of tempol on renal medullary hemodynamics in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 281: R1420-R1425, 2001[Abstract/Free Full Text].

12.   Hall, JE. The promise of translational physiology. Am J Physiol Regul Integr Comp Physiol 282: R1259-R1260, 2002[Free Full Text].

13.   Harris, RBS, Mitchell TD, Yan X, Simpson JS, and Redmann SM, Jr. Metabolic responses to leptin in obese db/db mice are strain dependent. Am J Physiol Regul Integr Comp Physiol 281: R115-R132, 2001[Abstract/Free Full Text].

14.   Janssen, BJA, Leenders PJA, and Smits JFM Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 278: R215-R225, 2000[Abstract/Free Full Text].

15.   Janssen, BJA, and Smits JFM Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol 282: R1545-R1556, 2002[Abstract/Free Full Text].

16.   Janssen, B, Debets J, Leenders P, and Smits J. Chronic measurement of cardiac output in conscious mice. Am J Physiol Regul Integr Comp Physiol 282: R928-R935, 2002[Abstract/Free Full Text].

17.   Just, A, Faulhaber J, and Ehmke H. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 279: R2214-R2221, 2000[Abstract/Free Full Text].

18.   Kennaway, DJ, Voultsios A, Varcoe TJ, and Moyer RW. Melatonin in mice: rhythms, response to light, adrenergic stimulation, and metabolism. Am J Physiol Regul Integr Comp Physiol 282: R358-R365, 2002[Abstract/Free Full Text].

19.   Koller, BH, Hagemann LJ, Doetschman T, Hagaman JR, Huang S, Williams PJ, First NL, Maeda N, and Smithies O. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 86: 8927-8931, 1989[Abstract/Free Full Text].

20.   Lazartigues, E, Dunlay SM, Loihl AK, Sinnayah P, Lang JA, Espelund JJ, Sigmund CD, and Davisson RL. Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res 90: 617-624, 2002[Abstract/Free Full Text].

21.   Lorenz, JN. A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice. Am J Physiol Regul Integr Comp Physiol 282: R1565-R1582, 2002[Abstract/Free Full Text].

22.   Ma, X, Abboud FM, and Chapleau MW. Analysis of afferent, central and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol 283: R1033-R1040, 2002[Abstract/Free Full Text].

23.   Mattson, DL. Long-term measurement of arterial blood pressure in conscious mice. Am J Physiol Regul Integr Comp Physiol 274: R564-R570, 1998[Abstract/Free Full Text].

24.   Morris, M, Means S, Oliverio MI, and Coffman TM. Enhanced central response to dehydration in mice lacking angiotensin AT1a receptors. Am J Physiol Regul Integr Comp Physiol 280: R1177-R1184, 2001[Abstract/Free Full Text].

25.   Nishiyama, A, and Navar LG. ATP mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 283: R273-R275, 2002[Free Full Text].

26.   Patton, EE, and Zon LI. The art and design of genetic screens: zebrafish. Nat Rev Genet 2: 956-966, 2001[Web of Science][Medline].

27.   Philipp, M, Brede M, and Hein L. Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283: R287-R295, 2002[Abstract/Free Full Text].

28.   Sandgaard, NCF, Andersen JL, Holstein-Rathlou NN, and Bie P. Aortic blood flow subtraction: an alternative method for measuring total renal blood flow in conscious dogs. Am J Physiol Regul Integr Comp Physiol 282: R1528-R1535, 2002[Abstract/Free Full Text].

29.   Schnermann, J. Adenosine mediates tubuloglomerular responses. Am J Physiol Regul Integr Comp Physiol 283: R276-R277, 2002[Free Full Text].

30.   Skøtt, O. Renin. Am J Physiol Regul Integr Comp Physiol 282: R937-R939, 2002[Free Full Text].

31.   Smith, BK, Volaufova J, and West DB. Increased flavor preference and lick activity for sucrose and corn oil in SWR/J vs. AKR/J mice. Am J Physiol Regul Integr Comp Physiol 281: R596-R606, 2001[Abstract/Free Full Text].

32.   Stauss, HM. Baroreceptor reflex function. Am J Physiol Regul Integr Comp Physiol 283: R284-R286, 2002[Free Full Text].

33.   Stengel, PW, Yamada M, Wess J, and Cohen ML. M3-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 282: R1443-R1449, 2002[Abstract/Free Full Text].

34.   Sun, D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, and Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98: 9983-9988, 2001[Abstract/Free Full Text].

35.   Todorov, V, Muller M, Schweda F, and Kurtz A. Tumor necrosis factor-alpha inhibits renin gene expression. Am J Physiol Regul Integr Comp Physiol 283: R1046-R1051, 2002[Abstract/Free Full Text].

36.   Warth, R, and Barhanin J. The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene. Am J Physiol Regul Integr Comp Physiol 282: R639-R648, 2002[Abstract/Free Full Text].

37.   Williams, TD, Chambers JB, Henderson RP, Rashotte ME, and Overton JM. Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice. Am J Physiol Regul Integr Comp Physiol 282: R1459-R1467, 2002[Abstract/Free Full Text].

38.   Zimmerman, MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, and Harken AH. Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. Am J Physiol Regul Integr Comp Physiol 283: R505-R512, 2002[Abstract/Free Full Text].


Am J Physiol Regul Integr Comp Physiol 284(1):R28-R30
0363-6119/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
Circ. Res.Home page
M. E. Reichelt, L. Willems, J. G. Molina, C.-X. Sun, J. C. Noble, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick
Genetic Deletion of the A1 Adenosine Receptor Limits Myocardial Ischemic Tolerance
Circ. Res., February 18, 2005; 96(3): 363 - 367.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehmke, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehmke, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online